Chinese covid vaccine effective in children and adolescents, a study claims
According to a study published in the Lancet Infectious Diseases journal, two doses of the Chinese covid vaccine are safe enough and have the capacity to produce strong antibodies response among children and youth of 3-17 years of age. The study is based on the phase half trial of the Chinese vaccine.
The trial was among 550 young people and it found that 90 percent of the children, who tool the vaccines developed and manufactured by Dinovac, developed antibodies resistant to covid, i.e Sars CoV 2. Most of the side effects were mainly moderate to mild with abre pain at the injection point.
The vaccine – 1.5 microgram (μg) or 3μg per dose was given by intramuscular injection in two doses, one was at day 0 and day 28.Adverse reactions was oberserved within 28 days of 1 dose and it occurred in 56 (26 per cent) of 219 participants among those who had taken the 1.5μg group. Another adverse raections were reported in 63 (29 per cent) of 217 participants in the group of 3μg group, and 27 (24 per cent) of 114 in the remaining control group.
Keeping these data in mind, The researchers suggested two 3μg doses of the Covid-19 vaccine for children and adolescents between the age group of 3-17 years based on their actions.For latest updates and trending news on cricket, world, business and technology, stay tuned to the latest posts of The Midget Herald.